111 related articles for article (PubMed ID: 21067945)
1. Cognitive and behavioral effects of lamotrigine and carbamazepine monotherapy in patients with newly diagnosed or untreated partial epilepsy.
Lee SA; Lee HW; Heo K; Shin DJ; Song HK; Kim OJ; Lee SM; Kim SO; Lee BI
Seizure; 2011 Jan; 20(1):49-54. PubMed ID: 21067945
[TBL] [Abstract][Full Text] [Related]
2. Effects of lamotrigine on cognition and behavior compared to carbamazepine as monotherapy for children with partial epilepsy.
Eun SH; Eun BL; Lee JS; Hwang YS; Kim KJ; Lee YM; Lee IG; Lee M; Ko TS; Kim JT; Eom S; Kim HD
Brain Dev; 2012 Nov; 34(10):818-23. PubMed ID: 22521904
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
[TBL] [Abstract][Full Text] [Related]
4. The effect of recurrent seizures on cognitive, behavioral, and quality-of-life outcomes after 12 months of monotherapy in adults with newly diagnosed or previously untreated partial epilepsy.
Lee SA; Kim MJ; Lee HW; Heo K; Shin DJ; Song HK; Kim OJ; Kim SO; Lee BI
Epilepsy Behav; 2015 Dec; 53():202-8. PubMed ID: 26594847
[TBL] [Abstract][Full Text] [Related]
5. A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure.
Gillham R; Kane K; Bryant-Comstock L; Brodie MJ
Seizure; 2000 Sep; 9(6):375-9. PubMed ID: 10985991
[TBL] [Abstract][Full Text] [Related]
6. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly.
Saetre E; Perucca E; Isojärvi J; Gjerstad L;
Epilepsia; 2007 Jul; 48(7):1292-302. PubMed ID: 17561956
[TBL] [Abstract][Full Text] [Related]
7. The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults.
Steinhoff BJ; Ueberall MA; Siemes H; Kurlemann G; Schmitz B; Bergmann L;
Seizure; 2005 Dec; 14(8):597-605. PubMed ID: 16278088
[TBL] [Abstract][Full Text] [Related]
8. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN
Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401
[TBL] [Abstract][Full Text] [Related]
9. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
Zeng K; Wang X; Xi Z; Yan Y
Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy.
Werhahn KJ; Trinka E; Dobesberger J; Unterberger I; Baum P; Deckert-Schmitz M; Kniess T; Schmitz B; Bernedo V; Ruckes C; Ehrlich A; Krämer G
Epilepsia; 2015 Mar; 56(3):450-9. PubMed ID: 25684224
[TBL] [Abstract][Full Text] [Related]
11. Quality of life improvement with conversion to lamotrigine monotherapy.
Cramer JA; Hammer AE; Kustra RP
Epilepsy Behav; 2004 Apr; 5(2):224-30. PubMed ID: 15123024
[TBL] [Abstract][Full Text] [Related]
12. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy.
Reunanen M; Dam M; Yuen AW
Epilepsy Res; 1996 Mar; 23(2):149-55. PubMed ID: 8964276
[TBL] [Abstract][Full Text] [Related]
13. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group.
Brodie MJ; Overstall PW; Giorgi L
Epilepsy Res; 1999 Oct; 37(1):81-7. PubMed ID: 10515178
[TBL] [Abstract][Full Text] [Related]
14. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy.
Blum D; Meador K; Biton V; Fakhoury T; Shneker B; Chung S; Mills K; Hammer A; Isojärvi J
Neurology; 2006 Aug; 67(3):400-6. PubMed ID: 16894098
[TBL] [Abstract][Full Text] [Related]
15. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
Helmstaedter C; Witt JA
Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
[TBL] [Abstract][Full Text] [Related]
16. Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy.
Brodie MJ; Wilson EA; Wesche DL; Alvey CW; Randinitis EJ; Posvar EL; Hounslow NJ; Bron NJ; Gibson GL; Bockbrader HN
Epilepsia; 2005 Sep; 46(9):1407-13. PubMed ID: 16146435
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological outcomes in newly diagnosed epilepsy.
Mohanraj R; Brodie MJ
Epilepsy Behav; 2005 May; 6(3):382-7. PubMed ID: 15820347
[TBL] [Abstract][Full Text] [Related]
18. Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine.
Sethi A; Chandra D; Puri V; Mallika V
Neurol India; 2002 Sep; 50(3):359-63. PubMed ID: 12391470
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
Baulac M; Brodie MJ; Patten A; Segieth J; Giorgi L
Lancet Neurol; 2012 Jul; 11(7):579-88. PubMed ID: 22683226
[TBL] [Abstract][Full Text] [Related]
20. Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures.
Zhou B; Zhang Q; Tian L; Xiao J; Stefan H; Zhou D
Epilepsy Behav; 2008 Feb; 12(2):305-10. PubMed ID: 18024209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
